Seven UnitedHealth Group shareholders are calling on the health care conglomerate to produce a report on how often its policies lead to denied or delayed care, and the effects on patients and the economy.
The proposal, which could go up for a vote by UnitedHealth’s investors at the company’s annual meeting later this year, comes as the company is under tremendous public scrutiny for tactics such as prior authorization and care denials. The killing of the CEO of UnitedHealth’s health insurance business in early December ignited a firestorm of anger — not against the alleged killer, but against health insurers like UnitedHealth who many blame for the industry’s dysfunction.
The shareholders who filed the proposal are members of the Interfaith Center on Corporate Responsibility, a nonprofit coalition of more than 300 institutional investors that organizes around issues like health equity, climate, and labor rights. Much of the group’s work in recent years has focused on how drugmaker policies affect access to treatments.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
